Evidence map›Paper›PMID 29731962›Full record

ArticleOncotarget2018

Gamma-Klotho exhibits multiple roles in tumor growth of human bladder cancer.

Shunta Hori, Makito Miyake, Yoshihiro Tatsumi, Yosuke Morizawa, Yasushi Nakai, Sayuri Onishi, Kenta Onishi, Kota Iida, Daisuke Gotoh, Nobumichi Tanaka and 1 more

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Role of Fibroblast Growth Factor 23 (FGF23) and αKlotho in Cancer.Frontiers in cell and developmental biology · 2020
    Review
  14. Frontiers in oncology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Shunta HoriDepartment of Urology, Nara Medical University, Kashihara-Shi, Nara 634-8522, Japan.
Makito MiyakeDepartment of Urology, Nara Medical University, Kashihara-Shi, Nara 634-8522, Japan.
Yoshihiro TatsumiDepartment of Urology, Nara Medical University, Kashihara-Shi, Nara 634-8522, Japan.
Yosuke MorizawaDepartment of Urology, Nara Medical University, Kashihara-Shi, Nara 634-8522, Japan.
Yasushi NakaiDepartment of Urology, Nara Medical University, Kashihara-Shi, Nara 634-8522, Japan.
Sayuri OnishiDepartment of Urology, Nara Medical University, Kashihara-Shi, Nara 634-8522, Japan.
Kenta OnishiDepartment of Urology, Nara Medical University, Kashihara-Shi, Nara 634-8522, Japan.
Kota IidaDepartment of Urology, Nara Medical University, Kashihara-Shi, Nara 634-8522, Japan.
Daisuke GotohDepartment of Urology, Nara Medical University, Kashihara-Shi, Nara 634-8522, Japan.
Nobumichi TanakaDepartment of Urology, Nara Medical University, Kashihara-Shi, Nara 634-8522, Japan.
Kiyohide FujimotoDepartment of Urology, Nara Medical University, Kashihara-Shi, Nara 634-8522, Japan.
Nara Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alpha-Klotho (KLα) and beta-Klotho (KLβ) have recently been reported to correlate with cancer prognosis in some malignancies and we previously reported the association between KLα, KLβ, and urothelial carcinoma of the bladder (UCB), indicating that KLβ acts as a tumor promoter. However, the association between gamma-Klotho (KLγ) and cancer prognosis remains unclear. In the present study, we evaluated the association between KLγ and UCB. To evaluate the effect of KLγ on human bladder cancer cell lines

Indexed as

apoptosiscancer prognosisepithelial-mesenchymal transitiongamma-Klothourothelial carcinoma

Identifiers

PMID29731962
PMCPMC5929405
OpenAlexW2801585745

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.